HLEGLAS NSI Week ended 07 Aug 2026

Weekly Investor Report

HLE Glascoat Limited · Industrials · Specialty Industrial Machinery

Open interactive chart View report data
Latest close 467.0 INR
9.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 31.8% above the Trend Line and sits at 52.7% of its 52-week range. The latest completed week returned 9.6%, after a 11.5% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 52/100.

Setup score 66 out of 100
Latest Close 467.0 INR 7 Aug 2026
1W Return 9.6% latest completed week
4W Return 11.5% short-term follow-through
12W Return 47.2% quarterly tape
Trend Breadth 38.5% 20 of 52 weeks active
Volume Ratio 2.7x vs 13-week average
What is working
  • The trend backdrop is active with a 3-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 9.6% Latest completed week; four-week move 11.5%. Indicator stack 32/78 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 56.38% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 52/100 20 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 31.8% above the Trend Line and sits at 52.7% of its 52-week range. The latest completed week returned 9.6%, after a 11.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5512-week average 0.27

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.55Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 11.5% over four weeks, 47.2% over 12 weeks, and 8.8% over one year. The current trend has remained active for 3 consecutive weeks.

Performance by holding period

1W9.6%
4W11.5%
12W47.2%
26W24.8%
52W8.8%
Active trend streak3 weeks
Active weeks in one year20
Trend breadth38.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.34Latest activity-pressure read.
Pressure change51.8%Four-week change in activity pressure.
Leadership14.61Latest relative-leadership reading.
RS change214.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength51/100Blend of value, momentum, and quality. Underlying universe rank 50; rank 1 is best.
Value25/100Relative valuation strength. Underlying universe rank 76; rank 1 is best.
Quality83/100Profitability and accounting quality. Underlying universe rank 18; rank 1 is best.
Momentum69/100Medium-term price momentum. Underlying universe rank 32; rank 1 is best.
Growth66/100Revenue and earnings growth. Underlying universe rank 35; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework28/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
67.9x
Price divided by trailing earnings.
Price / sales
2.4x
Market value relative to trailing revenue.
EV / EBITDA
25.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
53.3%
Gross profit retained from each unit of revenue.
Operating margin
7.6%
Operating profit retained from revenue.
Free-cash-flow margin
7.8%
Free cash flow generated from revenue.
Return on invested capital
9.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
31.7%
Latest one-year revenue growth.
EPS growth
-11.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
55.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.2%
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 20 relevant articles.

3 positive · 16 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-29.4%Distance below the 52-week high.
13-week volatility7.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+20.3%Week of 5 Jun.
Worst week-13.7%Week of 13 Feb.
Latest week+9.6%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains7
Flat weeks0
Modest losses8
Sharp losses5
Recent vol7.0%13-week weekly-return volatility.
Base vol7.3%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape60/100

Trend, activity pressure, participation, and risk combine to a 60/100 tape read.

 Indicator analysis54/100

Latest 12-week confirmation: trend 3/12, activity pressure 12/12, relative leadership 5/12.

Activity pressure 0.55; No reversal markers Next-Week ExpectancyPositive 56.38%

Next-week expectancy is positive with a 56.38% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors56/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 71; Small Cap Core rank 77 SVQF28/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 1127.5 of 1576 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment52/100

Weighted news tone is neutral across 20 relevant articles.

HLE Glascoat Number of Employees 2026 | Employee Count & Headcount Data Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 2026467.0 INR9.6%354.2 INR422.2 INR1.3414.612.8MOn
31 Jul 2026426.2 INR1.7%353.5 INR423.0 INR1.335.56591.1KOn
24 Jul 2026419.0 INR-0.7%354.3 INR424.3 INR1.236.421.3MOn
17 Jul 2026422.0 INR0.7%355.1 INR425.7 INR1.074.741.8MOff
10 Jul 2026419.0 INR9.9%355.9 INR427.1 INR0.894.654.8MOff
3 Jul 2026381.2 INR0.2%357.3 INR428.6 INR0.73-4.97120.8KOff
26 Jun 2026380.5 INR1.5%359.6 INR430.5 INR0.71-4.510Off
19 Jun 2026375.0 INR-1.7%362.8 INR432.2 INR0.60-5.8870.1KOff
12 Jun 2026381.4 INR-0.8%365.9 INR434.0 INR0.64-2.83326.2KOff
5 Jun 2026384.5 INR20.3%369.4 INR435.8 INR0.56-1.13249.4KOff
29 May 2026319.8 INR-1.5%376.0 INR437.6 INR0.55-18.47305.8KOff
22 May 2026324.7 INR2.3%384.5 INR439.6 INR0.48-18.15893.0KOff
15 May 2026317.4 INR-10.0%391.3 INR441.4 INR0.23-19.98591.7KOff
8 May 2026352.6 INR10.1%396.9 INR443.3 INR0.00-12.88653.6KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context